[Medication management of COPD].
Marina Gueçamburu1, Maeva Zysman2
1Service des maladies respiratoires, CHU Bordeaux, France.
La Revue Du Praticien
|February 8, 2024
Summary
Managing chronic obstructive pulmonary disease (COPD) involves inhaled therapies like long-acting bronchodilators (LABA/LAMA) and considering biomarkers for personalized treatment. De-escalation of inhaled corticosteroids (ICS) is also crucial for COPD medication management.
Area of Science:
- Pulmonology
- Pharmacology
Context:
- Chronic obstructive pulmonary disease (COPD) management relies on a stepwise approach to inhaled therapies.
- Current guidelines emphasize bronchodilator use for symptom control and exacerbation prevention.
Purpose:
- To outline the current medication management strategies for COPD.
- To highlight the role of escalating and de-escalating inhaled therapies based on patient response and biomarkers.
Summary:
- Initial COPD treatment involves short-acting bronchodilators, progressing to long-acting muscarinic antagonists (LAMA) or long-acting beta2-agonists (LABA) for persistent symptoms.
- Dual or triple therapy may be initiated if initial treatments are insufficient. De-escalation of inhaled corticosteroids (ICS) is considered for managing side effects or lack of efficacy.
- Biomarkers, such as blood eosinophils, are increasingly important for guiding therapy, potentially expanding options with biotherapeutics for specific COPD subtypes.
Impact:
- Provides a framework for optimizing COPD pharmacotherapy.
- Emphasizes personalized treatment strategies based on symptom burden, exacerbation history, and biomarkers.
- Informs clinical decision-making regarding inhaled corticosteroid use and the potential of novel biotherapies.
More Related Videos
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:23Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442